The QualityStocks Daily Friday, September 13th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (TNTY) +100.20%

SmallCapRelations (CSRH) +77.00%

StocksToBuyNow (CLWD) +22.50%

The QualityStocks Daily Stock List

Jones Soda Co. (JSDA)

Zacks, StockTwits, OTC Markets, GlobeNewswire, Stockhouse, Cannabis Life Network, Dividend Investor, Last10k, Investing.com, 4-Traders, Hemp Industry Daily, GuruFocus, Stockopedia, and TradingView reported beforehand on Jones Soda Co. (JSDA), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Jones Soda Co., together with its subsidiaries, develops, produces, markets, and distributes beverages chiefly in the United States and Canada. It is a leader in the craft soda category and is known for its unique branding and authentic connection to its consumers. The Company sells and distributes its products through a network of independent distributors, and directly to its national and regional retail accounts. Jones Soda is based in Seattle, Washington. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Jones Soda markets and distributes premium beverages under the Jones® Soda and Lemoncocco® brands. Jones Soda is made with pure cane sugar and other high-quality ingredients. Jones Soda is known for packaging that incorporates ever-changing photos sent in from its customers. The Company’s diverse product line offers pure cane sugar soda, zero-calorie soda, as well as Lemoncocco non-carbonated premium refreshment.

Jones Soda’s flavor lineup includes traditional favorites such as Cola, Root Beer, Cream Soda & Orange & Cream. The Company also offers inventive options including Blue Bubblegum, Green Apple, Strawberry Lime and Fufu Berry. Its portfolio includes Jones Pure Cane Soda, Jones Sugar Free, Jones Cane Sugar fountain products, Spiked Jones (a hard cider soda created for its 21+ fans) and also its sister brand Lemoncocco. This is a non-carbonated beverage inspired by the iconic beverage stands in Rome, Italy.

Jones Soda announced this past July that it completed a $9.0 million strategic financing with HeavenlyRx Ltd. HeavenlyRx is a portfolio company of SOL Global Investments focused on acquiring innovative brands to sell CBD (cannabidiol) and hemp-infused products. With the agreement, HeavenlyRx purchased 15.0 million shares of Jones Soda at a price of $0.60 per share for a total of $9.0 million.

Furthermore, Jones Soda issued HeavenlyRx a warrant with a 12-month term to purchase up to an additional 15.0 million shares at an exercise price of $0.78 per share, which provides Jones Soda the potential for an additional $11.7 million in capital. Jones Soda plans to use the capital to further increase and enhance its existing beverage portfolio, along with pursuing the development of new extensions to Jones products. This includes the potential commercialization of CBD-infused beverages.

Recently, Jones Soda appointed Mr. Paul Norman and Mr. Clive Sirkin to its Board of Directors. The two appointments were nominated by Heavenly Rx in connection with its strategic financing agreements with Jones Soda and certain other Company shareholders. Furthermore, Vanessa Walker and Ray Silcock will be stepping down from Jones Sodas’ Board, which will now comprise five members and two vacancies, for a total of seven Board seats.

Jones Soda Co. (JSDA), closed Friday's trading session at $0.49625, up 2.9564%, on 138,459 volume with 30 trades. The average volume for the last 3 months is 107,795 and the stock's 52-week low/high is $0.219999998/$0.978999972.

chart

Notox Technologies Corp. (NTOX)

Penny Stock Hub, Market Screener, Stockwatch, Last10k, Stock Target Advisor, PredictWallStreet, Wallstreet Online, Market Exclusive, Stockopedia, Wallet Investor, TradingView, Stockhouse, Simply Wall St, and Investors Hangout reported earlier on Notox Technologies Corp. (NTOX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Notox Technologies Corp. concentrates on developing and commercializing unique technologies. The Company is doing so chiefly via its wholly-owned Nevada subsidiary Notox Bioscience, Inc. Notox is working to market a credible, non-toxic alternative to Botox and subsequently develop other features of its Notox technology, including drug-free pain management, body countering, skin tightening and anti-perspiration. A Nevada corporation, Notox Technologies lists on the OTCQB. The Company has its head office in Richmond Hill, Ontario.

Notox Technologies is also working to build its distribution capabilities for other medical and aesthetic products globally. The Company announced in February 2019 that it entered into a relationship with the Veterans Global Initiative Foundation. This relationship is to raise capital for the testing, development, and commercialization of Notox’s drug-free pain management solutions, principally for the benefit of military veterans who suffer from pain. Notox Technologies and the VGI Foundation are working together to provide the Notox treatment either at no cost or at deeply discounted rates to those veterans who need relief the most and continue to suffer in cases where other treatments have not worked.

Notox Technologies has transitioned over the past two years into developing, commercializing and promoting its patented Notox aesthetic and drug-free pain management platform. This is following its acquisition of the associated intellectual property (IP) rights in 2016. That patented IP was originally developed by Dr. Frank Papay, MD FACS Chairman Dermatology and Plastic Surgery Institute, Cleveland Clinic, and is owned by The Cleveland Clinic Foundation. Notox Technologies announced this past July that it entered into a binding Letter of Intent (LOI) with Xthetica, Inc., a private Canadian aesthetic and medical beauty distributor, to acquire certain of Xthetica's assets in consideration for the issuance of shares and warrants of Notox Technologies to the sole shareholder of Xthetica, Mr. Manny Kapur. Those assets include Xthetica's rights and obligations under a series of distribution agreements with manufacturers of aesthetic and medical beauty products, access to all of Xthetica's current inventory, and also the goodwill of Xthetica.

At present, Xthetica services a large number of clinics in the Canadian market. Via this acquisition, Notox Technologies is expected to gain direct access to greater than 200 of those clinics along with the right to distribute an assortment of products and services now controlled by Xthetica.

Notox Technologies Corp. (NTOX), closed Friday's trading session at $4.50, even for the day, on 25 volume. The stock's 52-week low/high is $1.98000001/$4.50.

chart

RIWI Corp. (RWCRF)

Market Screener, Stock News Now, Macroaxis, TeleTrader, Investor Ideas, Research Pool, InvestorX, TMXmoney, Dividend Investor, Stockwatch, Wallet Investor, TradingView, Before It’s News, Stockhouse, Proactive Investors, Nasdaq, and Seeking Alpha reported beforehand on RIWI Corp. (RWCRF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

RIWI Corp. is a worldwide trend-tracking and prediction technology enterprise listed on the OTC Markets. The Company, on a monthly or annual subscription basis, offers its clients tracking surveys, continuous risk monitoring, predictive analytics, and ad effectiveness tests in all nations. RIWI has offices in Toronto, Ontario; Vancouver, British Columbia; and Chelsea, London.

The Company invented worldwide, continuous, agile and privacy-compliant data collection. It reaches disengaged populations online. It is anonymous and secure, safe for respondents, and no personally identifiable information is ever captured. It features randomized recruitment and response, and also a continuous, real-time data feed to identify changes.

In essence, RIWI’s technology provides continuous predictive data using online surveys. The Company delivers real-time analytics-infused insights to the finance, humanitarian aid, and security sectors via data dashboards. At any time, its clients can download all raw data into MS Excel or SPSS.

RIWI offers international surveys, predictive analytics, message testing, and risk monitoring anywhere worldwide through long-term agreements and monthly subscriptions. Its data-on-demand offerings include time-series analysis; predictions about major geopolitical events that considerably influence equities and commodities markets; and real-time analytics-infused insights about fast-changing investor sentiment and technology trends.

In August, RIWI reported its financial results for the three and six months ended June 30, 2019. The Company's Q2 Revenue was its highest in its history. Revenue increased by 23 percent to $841,431, versus the three months ended June 30, 2018. For the six months ended June 30, 2019, Revenue increased by 46 percent, to $1,515,006.

RIWI had a Net Loss of $151,052 for the three months ended June 30, 2019. This was primarily affected by the non-cash share-based payment expense of $538,392 related to the stock option grant in May 2019 to Non-Executive Directors. For the six months ended June 30, 2019, RIWI was profitable, having Net Income of $85,848 despite the non-cash share-based payment expense. For the last 12 months, the Company increased its revenue year-over-year by 72 percent, reaching Revenues of $3,142,230 for the 12 months ended June 30, 2019, versus the same period last year.

Also in August, RIWI announced that it has been selected to present at the fourth annual MicroCap Leadership Summit, hosted by MicroCapClub, on Friday, September 27, 2019, at the Westin Chicago Northwest Hotel in Itasca, Illinois, and also at the 11th annual TEDx Toronto event on Saturday, October 26, 2019, at Toronto’s Evergreen Brick Works. Ms. Danielle Goldfarb, RIWI’s Head of Global Research, will be speaking at TEDx Toronto on October 26, 2019.

RIWI Corp. (RWCRF), closed Friday's trading session at $1.75, even for the day, on 3,400 volume. The average volume for the last 3 months is 1,876 and the stock's 52-week low/high is $0.986400008/$2.49720001.

chart

Whitecap Resources, Inc. (SPGYF)

StocksBeat, Seeking Alpha, Market Screener, Nasdaq, GuruFocus, Wallmine, Investing.com, Wallet Investor, Mining.com, Tech Know Bits, TradingView, Street Insider, 4-Traders, and Dividend Investor reported beforehand on Whitecap Resources, Inc. (SPGYF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Whitecap Resources, Inc. acquires and develops petroleum and natural gas properties in Canada. Its principal properties are situated in West Central Alberta, Northwest Alberta and British Columbia, Southeast Saskatchewan, West Central Saskatchewan, and Southeast Saskatchewan. Since inception in September of 2009, the Company has accumulated a considerable light oil resource base. This base provides a strong foundation for continued growth and results on a per share basis. Whitecap Resources is headquartered in Calgary, Alberta.

Whitecap Resources employs a strategy of acquiring sustainable assets with large Discovered Petroleum Initially In Place (DPIIP) and low current recovery factors and moving them through the development chain through converting contingent resources - probable reserves - proven reserves - producing reserves (cash flow).

The Company is an oil-weighted growth company. It pays a monthly cash dividend to its shareholders. Whitecap Resources’ focus is on providing sustainable dividends and profitable per share growth enhanced by value added acquisitions. Its asset portfolio has stable production and low base declines. This provides Whitecap shareholders with a predictable cash flow stream for monthly dividend payments. In addition, the large resource in place enables Whitecap Resources to grow on a per share basis.

Whitecap’s Boundary Lake property is primarily in northeast British Columbia on the Alberta/British Columbia border, just east of Fort St. John. The Company’s Deep Basin properties, which include Karr, Simonette, Kakwa, Elmworth and Wapiti, are southwest of Grande Prairie, Alberta. Its Weyburn property is in southeast Saskatchewan. The main reservoirs undergoing development are the Midale and Frobisher.

Whitecap’s Cardium producing areas in West Central Alberta are primarily in the Pembina, Garrington, Ferrier and Willesden Green areas. Concerning its Viking assets, its Lucky Hills, Whiteside, Kerrobert, and Eagle Lake areas are in West Central Saskatchewan. The Company’s southwest Saskatchewan assets are concentrated west of Swift Current, Saskatchewan. They are characterized by predictable low base decline, medium crude oil (21° API) production.

In August, Whitecap Resources announced that it elected to exercise a more cautious approach for the balance of 2019 through reducing its 2019 second half capital expenditures program by 17 percent to $250 million from $300 million to provide greater optionality and improve near term free funds flow. The anticipation is that the Company’s full year 2019 capital expenditure program will be $400 million. This is $50 million lower than its earlier guidance of $450 million.

Whitecap Resources’ 2019 average production guidance of 70,000 to 72,000 boe/d remains unchanged despite the decrease in capital expenditures. The Company now anticipates increasing production 6 percent to 74,000 to 75,000 boe/d in Q4 of 2019 from the Q2 average production of 70,611 boe/d. On strip pricing, anticipated 2019 free funds flow is roughly $135 million with a total payout ratio of 80 percent versus $95 million and a total payout ratio of 86 percent before the decreased capital program.

Whitecap Resources, Inc. (SPGYF), closed Friday's trading session at $3.332, up 0.969697%, on 14,115 volume with 23 trades. The average volume for the last 3 months is 119,368 and the stock's 52-week low/high is $2.56999993/$6.4499998.

chart

Fission Uranium Corp. (FCUUF)

Zacks, Wealth Daily, TipRanks, Junior Mining Network, Energy and Capital, Stock News Now, Metals News, Resource Stock Digest, Streetwise Reports, Wallet Investor, Resource World, and Stockhouse reported earlier on Fission Uranium Corp. (FCUUF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Fission Uranium Corp. engages in the exploration and development of uranium properties. It owns the award-winning PLS (Patterson Lake South) uranium project, host to the near-surface, high-grade Triple R deposit - part of the largest mineralized trend in the Athabasca Basin region. Since discovery in 2012, significant new high-grade zones have been discovered each year. Recently, exploration drilling encountered mineralization 600m west of the trend. OTCQX-listed, Fission Uranium is headquartered in Kelowna, British Columbia.

The Company is concentrating on continued exploration at the large and highly-prospective PLS project and further development of the Triple R deposit. Patterson Lake South (PLS) is host to the aforementioned Triple R deposit - the most significant high grade shallow depth deposit in the region.

The Triple R deposit is open in manifold directions, especially westwards, towards the high-grade boulder field. A preliminary economic study conducted in 2015 shows the Triple R has the potential for an OPEX of $14.02/lb. This would make it one of the world's lowest cost uranium producers.

Fission Uranium has 100 percent ownership of the PLS Property. The Property comprises 17 mineral claims totaling 31,039 ha positioned on the southwest margin of the Athabasca Basin. The property is accessible by all-weather Highway 955 that continues north through the area of the UEX-AREVA Shea Creek deposits to the past producing Cluff Lake uranium mine.

Fission Uranium announced this past May that it filed a technical report on the Triple R Deposit at its PLS project, pursuant to National Instrument 43-101 "Standards of Disclosure for Mineral Projects" (NI 43-101). The Report summarizes the Pre-Feasibility Study that highlights the strong economics and long-term potential of the Triple R deposit.

Mineral Reserves were estimated for the Project, based on a hybrid (underground plus open pit) approach to production at PLS. Moreover, the Report recognizes the potential for an underground-only approach that was completed to PEA level and shows considerable advantages. This includes lower capital expenditures and shorter construction time. As a result, Fission Uranium is advancing this scenario to Prefeasibility Study stage. Subsequently in July, Fission Uranium announced that, further to its successful Prefeasibility Study (PFS) outlining a hybrid (open pit plus underground) mining option for the Triple R deposit on its' Patterson Lake South (PLS) property, it has started a PFS to fully analyze an underground-only mining approach.

In August, Fission Uranium announced assay results from three dual purpose holes drilled during the Winter 2019 program at its' PLS property. The holes tested outside of the Triple R deposit's present high-grade domain with the aim of confirming areas of future growth and obtaining further geotechnical data for mine planning.

All three returned considerable high-grade intervals that were previously not accounted for. Holes PLS19-PW-09 and PLS19-PW-10 intersected high-grade mineralization outside of the present high-grade domain of the R780E zone, therefore showing the potential for further high-grade zone growth. Of note is hole PLS19-PW-09 (line 735E) that intersected 41.0m of total composite uranium mineralization, including intervals such as 5.0m @ 22.88% U3O8 in 38.0m @ 3.52% U3O8.

Fission Uranium Corp. (FCUUF), closed Friday's trading session at $0.29484, up 2.233%, on 79,865 volume with 32 trades. The average volume for the last 3 months is 210,128 and the stock's 52-week low/high is $0.2386/$0.584699988.

chart

International Spirits & Wellness Holdings, Inc. (ISWH)

Undergroundstocks, OTC Markets, NewMediaWire, Market Screener, Investor Ideas, Investor News, Financial Buzz, Spotlight Growth, Stock News Feed, and Insider Tracking reported earlier on International Spirits & Wellness Holdings, Inc. (ISWH), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

International Spirits & Wellness Holdings, Inc. (ISWH) is a top-tier brand incubator in the Global Wine & Spirits and CBD-Infused Products markets. The Company is an authorized importer, licensor, and marketer of premium beverage brands, with sales of inventive products and brands worldwide. The Company formerly went by the name International Spirits & Beverage Group, Inc. It changed its name to International Spirits & Wellness Holdings, Inc. this past July. ISWH is headquartered in Nevada and lists on the OTC Markets.

ISWH develops and grows brands through all phases. This includes concept creation, product development, market positioning, sales and marketing. Its aim is to be a worldwide innovation leader within the alcohol beverage and cannabis industries. The Company will source early stage brands, existing brands with unrealized potential, and create in-house brands that raises innovation and expectations with trade and consumer. Furthermore, ISWH has partnered with Bengala Technologies to develop and commercialize enterprise and B2B (Business to Business) software technology products targeting the logistics and supply-chain market.

ISWH’s latest brand is P19. It is the Company’s initial entrance into the booming CBD (cannabidiol) space. ISWH partnered with best-in-class CBD experts at BioPulse Labs. P19 was created around developing the finest CBD products including gummies, topicals, tinctures, and more.

Currently, the Company’s Wine and Spirit portfolio is led by Besado Tequila. This is ISWH’s unique entrance within the growing ultra-premium tequila segment. Additionally, its Dziaq (dee-zee-ack) Liqueur re-brand to a wine based ready-to-serve cocktail line allows for considerably greater distribution channels (2 x spirit based alternatives).

ISWH has completed the final step in its transformation from a pure-play in the adult beverage industry to a diversified business, which retains exposure to the beverage market via its award-winning spirits products. However, it now includes a strongly positioned and fast growing Health and Wellness segment with a core emphasis on the CBD products market and the home healthcare industry. The final step came with speedy notice from FINRA that they approved the Company’s symbol change request from “ISBG” to “ISWH” to better reflect its new business model, corporate name, and official description of business activities.

ISWH has now established itself as a health and wellness enterprise with a focus on reshaping the CBD products market via state-of-the-art nanotechnology processes, developing a broad spectrum of nano-infused CBD gummies and beverages formulations. These products will sell through its website, and also through established wholesale and retail distribution channels.

This week, ISWH announced that it is on course to post its first ever quarter of profitability on an EBITDA (Earnings Before Interest, Tax, Depreciation and Amortization) basis in its fiscal third quarter (ending September 30, 2019). In addition, it now expects nominal revenues and quarterly year/year revenue growth rate will surpass the strong top-line results filed by the Company for its Q2 quarter ended June 30, 2019.

International Spirits & Wellness Holdings, Inc. (ISWH), closed Friday's trading session at $0.0006, up 20.00%, on 48,107,900 volume with 48 trades. The average volume for the last 3 months is 37,440,808 and the stock's 52-week low/high is $0.000399999/$0.039999999.

chart

Jaguar Health, Inc. (JAGX)

Stock Twits, Infront Analytics, Alpha Stock News, Proactive Investors, TradingView, Market Screener, Stockwatch, Street Insider, Stockhouse, Investing.com, and Super Stock Screener reported previously on Jaguar Health, Inc. (JAGX), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Jaguar Health, Inc. is a commercial stage pharmaceutical company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Its wholly-owned subsidiary is Napo Pharmaceuticals, Inc. Napo centers on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the worldwide marketplace from plants used traditionally in rainforest areas. Jaguar Health is based in San Francisco, California and its shares trade on the Nasdaq Global Select Market (NasdaqGS).

Jaguar Health’s mission is to identify human and animal health market opportunities where it can develop targeted products that leverage its broad intellectual property (IP) portfolio, deep pipeline, and extensive botanical library. The Company’s emphasis is naturally derived health solutions for humans and animals around the world.

Jaguar Health’s Mytesi® (crofelemer) product is approved by the U.S. FDA (Food and Drug Administration) for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. MYTESI® is not indicated for the treatment of infectious diarrhea.

Jaguar Health announced earlier in the summer that Indena S.p.A., one of the two contract manufacturers of the active pharmaceutical ingredient (API) in crofelemer, successfully developed and implemented an improved crofelemer manufacturing process. This effectively boosts yield and attains reduce cost via increased manufacturing efficiencies. This is while keeping the same phytochemical profile without compromising product quality, safety, purity and efficacy.

The modified process enables Jaguar Health's wholly-owned human-health subsidiary, Napo Pharmaceuticals, to support the increased crofelemer manufacturing demand expected if crofelemer receives FDA approval for new indications. This includes approval for the symptomatic relief of cancer therapy-related diarrhea (CTD). Indena (Milan, Italy) is a top CDMO provider, with a focus on complex small molecules and natural derivatives.

Last month, Jaguar Health announced that statistically significant top line results were achieved in a key preclinical pharmacological study to evaluate the effects of crofelemer on diarrhea induced in healthy dogs by a maximally tolerated dose of a specific tyrosine kinase inhibitor (TKI). The results of the Study, funded by a third-party cancer agent manufacturer of an FDA-approved TKI, are expected to provide additional scientific rationale and support for the use of crofelemer in providing symptomatic relief of non-infectious diarrhea in human patients receiving TKI-and/or-other targeted cancer therapy-containing regimens in future human clinical investigations. The top line results of the Study show that combined crofelemer groups demonstrated superior benefit for “responders” (p= 0.01).

This week, Jaguar Health announced that it promoted Mr. Jonathan Wolin to the expanded role of Chief of Staff, Chief Compliance Officer, and General Counsel. Mr. Wolin is an accomplished healthcare and biotechnology executive. He joined Jaguar Health in November of 2018. He previously held the title of Chief Compliance Officer and Corporate Counsel at the Company. Mr. Wolin has over 25 years of compliance, legal, and business experience in the life science, biotechnology, and healthcare fields.

Jaguar Health, Inc. (JAGX), closed Friday's trading session at $1.33, even for the day, on 1,174,936 volume with 3,041 trades. The average volume for the last 3 months is 1,096,486 and the stock's 52-week low/high is $1.00/$175.00.

chart

HedgePath Pharmaceuticals, Inc. (HPPI)

Simply Wall St, 4-Traders, Infront Analytics, Morningstar, MarketWatch, InvestorsHub, BUYINS.NET, Stockhouse, Dividend Investor, and Wallet Investor reported earlier on HedgePath Pharmaceuticals, Inc. (HPPI), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company headquartered in Tampa, Florida. It discovers, develops, and plans to commercialize front-line therapeutics for patients with cancer. The Company is looking to repurpose the Food and Drug Administration (FDA) approved antifungal pharmaceutical itraconazole as a potential treatment for cancer. HedgePath Pharmaceuticals lists on the OTC Markets Group’s OTCQB.

HedgePath is the exclusive United States licensee of a patented formulation of itraconazole, called SUBA-Itraconazole. Clinical studies have shown it to have more bioavailability than generic itraconazole. The Hedgehog signaling pathway is a significant regulator of cellular processes in vertebrates. This includes cell differentiation, tissue polarity, as well as cell proliferation.

The Company believes (based on published research) that inhibiting the Hedgehog pathway could delay or possibly prevent the development of certain cancers in humans. Leveraging research undertaken by key investigators in the field, HedgePath’s plan is to explore the effectiveness of SUBA-Itraconazole as an anti-cancer agent and to pursue its potential commercialization.

The design of “SUBA technology” (which stands for “Super Bioavailability”) is to improve the bioavailability of orally administered drugs that are poorly soluble. SUBA-Itraconazole is a patented formulation developed by Mayne Pharma. It has improved absorption and substantially reduced variability in comparison to generic itraconazole.

In August of 2018, HedgePath Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) confirmed HedgePath’s present clinical and regulatory pathway related to the Company’s SUBA™-Itraconazole as a treatment for Basal Cell Carcinoma (BCC) in patients with Basal Cell Carcinoma Nevus Syndrome (BCCNS, or Gorlin Syndrome).

This past December, HedgePath Pharmaceuticals announce that it entered into a revised Supply and License Agreement (SLA) with its majority stockholder Mayne Pharma Ventures Pty Ltd (Mayne Pharma), an affiliate of Mayne Pharma Group Limited. With the new SLA, Mayne Pharma will assume control of the regulatory and clinical development program for SUBA®-Itraconazole for the treatment of basal cell carcinoma nevus syndrome (SUBA-Itraconazole BCCNS) in expectation of conducting a worldwide Phase 3 pivotal clinical trial based on results attained in the Phase 2(b) trial conducted by HedgePath in the United States. Mayne Pharma will immediately assume responsibility for all future SUBA-Itraconazole BCCNS-related expenses.

HedgePath Pharmaceuticals, Inc. (HPPI), closed Friday's trading session at $0.0868, up 33.54%, on 50,054 volume. The average volume for the last 3 months is 5,357 and the stock's 52-week low/high is $0.0400/$0.3200.

chart

RespireRx Pharmaceuticals, Inc. (RSPI)

NetworkNewsWire, Penny Stock Tweets, Infront Analytics, Stockflare, Barchart, InvestorsHub, Stockopedia, Penny Stock Hub, Wallet Investor, Simply Wall St, Marketbeat, YCharts, Street Insider, Marketwired, Stockhouse, Daily Marijuana Observer, last10k, Investors Hangout, GuruFocus, MarketWatch, Stockwatch, 4-Traders, and Real Investment Advice reported earlier on RespireRx Pharmaceuticals, Inc. (RSPI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

RespireRx Pharmaceuticals, Inc. is a leader in the development of medicines for respiratory disorders and CNS indications, with a concentration on obstructive sleep apnea, attention deficit hyperactivity disorder (ADHD), spinal cord injury, other neurological conditions and drug-induced respiratory depression. RespireRx Pharmaceuticals has its corporate office in Glen Rock, New Jersey. The Company lists on the OTC Markets Group’s OTCQB.

RespireRx has filed over 400 patents in the U.S. and offshore that claim composition of matter, use, formulation, dosage, as well as mechanism of action. Use claims include treating sleep apnea and preventing or rescuing drug-induced respiratory depression, and also for improving memory and cognition, treating schizophrenia and other central nervous system (CNS) indications.    

The Company’s pharmaceutical candidates in development are derived from two platforms. One platform is the class of compounds called cannabinoids. This includes, in particular, Dronabinol. Dronabinol (D9-THC, D9-tetrahydrocannabinol) is an oral capsule drug product. Dronabinol (D9-THC) is a generic, orally active cannabinoid. It is undergoing testing for clinical efficacy in patients with obstructive sleep apnea (OSA).

RespireRx Pharmaceuticals (under a license agreement with the University of Illinois) has rights to patents claiming the use of cannabinoids for the treatment of sleep-related breathing disorders. Two Phase 2 clinical trials have been completed. Both have demonstrated substantial reductions in sleep apnea produced by dronabinol. 

Dronabinol is Food and Drug Administration (FDA) approved for the treatment of anorexia in AIDS patients and nausea and vomiting in cancer patients undergoing chemotherapy (Marinol®). It is a Schedule III drug available by prescription, with a low risk of addiction.

The other platform of medicines undergoing development by RespireRx is a class of proprietary compounds called ampakines. These act to enhance the actions of the excitatory neurotransmitter glutamate at AMPA glutamate receptor sites in the brain. Several ampakines, in oral and injectable form, are undergoing development by RespireRx for the treatment of an assortment of breathing disorders.

Recently, RespireRx Pharmaceuticals announcd the promotion of Mr. James Sapirstein to Executive Vice Chairman of the Board of Directors effective December 28, 2018. Mr. Sapirstein has served as a member of the Board of Directors since 2014. He expands his role within RespireRx Pharmaceuticals to assist with business development and fundraising activities to advance the development of the Company’s pipeline of neuromodulators with an emphasis on sleep apnea and neurologic and psychiatric disorders.

Mr. Sapirstein is a highly-regarded pharmaceutical industry executive. He has more than 35 years of success in building companies and leading the commercial launch of almost two dozen prescription drugs in the fields of CNS, infectious disease, and cancer. Mr. Sapirstein has worked at major pharmaceutical companies, Bristol-Myers Squibb, Hoffmann-LaRoche and Eli Lilly. He has also led commercial teams for biotechnology companies including Gilead Sciences and Serono Laboratories.

RespireRx Pharmaceuticals, Inc. (RSPI), closed Friday's trading session at $0.65, up 44.4444%, on 2,300 volume with 5 trades. The average volume for the last 3 months is 162 and the stock's 52-week low/high is $0.222000002/$1.10000002.

chart

IronClad Encryption Corporation (IRNC)

4-Traders, PennyStockHub, The Street, Simply Wall St, MarketWatch, InvestorsHub, OTC Markets, YCharts, Barchart, Investors Hangout, Stock News Now and TradingView reported earlier on IronClad Encryption Corporation (IRNC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

IronClad Encryption Corporation is a next-generation cyber defense company headquartered in Houston, Texas. Its strategic and tactical data protection solutions strengthen existing encryption methods. The Company’s technology can provide continuous authentication of encrypted data transmitted, creating much stronger defenses to most hacker attacks. IronClad Encryption lists on the OTC Markets’ OTCQB.

IronClad Encryption-powered solutions use the Company’s patented Dynamic Encryption and Perpetual Authentication technologies to make all known key-based encryption technologies almost impossible to compromise. Dynamic Encryption Technology eliminates vulnerabilities caused by exposure of any single encryption key through continually changing encryption keys and keeping the keys synchronized in a fault-tolerant way.

Dynamic Encryption technology eliminates the single point of failure problem inherent in single-key encryption techniques. IronClad’s key management system continuously produces synchronous keys between the sender and receiver. Each key is assigned to a small amount of data. Therefore, if a hacker were to access one of hundreds of millions of keys, the amount of data he would obtain would be almost useless.

IronClad Encryption has a partnership with Black Pearl Engineering Management, Inc. to co-develop ultra-secure products based on IronClad’s patented ultra-secure cybersecurity algorithms and methodologies. The joint venture (JV) operates under the name "Black ICE". It is initially focusing on network gateway products. BlackICE Barrier is the first product in a family of BlackICE products. BlackICE Barrier is specifically targeted at enterprises and industrial use cases where data and control systems require the highest level of security.

IronClad Encryption offers its ICEMicro. This is the world’s first context-free and natively-secure container. It enables all developers to take ownership of application data security. Employing ICEMicro, any developer can secure communication between containers across varied scheduling and orchestration platforms, IaaS services, transport-layer security protocols, and on-premises or hybrid environments utilizing Docker-compatible hypervisors.

Recently, IronClad Encryption announced that it received notice from the United States Patent and Trademark Office (USPTO) that six of its patents were allowed. The titles of the IronClad patents that have been provided a Notice of Allowance include: Securitization of Temporal Digital Communications with Authentication and Validation of User and Access Devices; User-Wearable Secured Devices Provided Assuring Authentication and Validation of Data Storage and Transmission; and Devices that Utilize Random Tokens Which Direct Dynamic Random Access.

Titles also include: Devices for Transmitting and Communicating Randomized Encrypted Data Utilizing Sub-Channels; Executable Coded Cipher Keys; and Combined Hidden Dynamic Random-Access Devices Utilizing Selectable Keys and Key Locators for Communicating Randomized Data together with Sub-Channels and Coded Encryption Keys.

IronClad Encryption Corporation (IRNC), closed Friday's trading session at $0.006, up 26.0504%, on 4,632,264 volume with 61 trades. The average volume for the last 3 months is 2,816,381 and the stock's 52-week low/high is $0.0041/$0.649999976.

chart

Regen BioPharma, Inc. (RGBP)

Small Cap Solutions, InvestorTrendz, Insider Financial, TopPennyStockMovers, YCharts, ProTrader, Emerging Growth, SmallCapVoice, Wall Street Mover, TheMicrocapNews, and The OTC Reporter reported earlier on Regen BioPharma, Inc. (RGBP), and today we highlight the Company, here at the QualityStocks Daily Newsletter. 

Regen BioPharma, Inc. is a biotechnology company listed on the OTC Markets’ OTCQB. The Company works to identify undervalued regenerative medicine applications in the immunotherapy and stem cell space. Its aim is to quickly advance these technologies through pre-clinical and Phase I/II clinical trials.  Checkpoint Immunology, Inc. is a wholly-owned subsidiary of the Company. Regen BioPharma has its head office in La Mesa, California.

At present, Regen BioPharma is focusing on checkpoint inhibitor and gene silencing therapies for treating cancer. Furthermore, it is focusing  on developing stem cell treatments for aplastic anemia. Fundamentally, the Company is working to increase the quality of life through therapies involving small molecules, stem cell treatments, and the body's own immune system.  It is currently developing products treating blood disorders employing small molecules and gene silencing (DiffronC) and treating cancer with immunotherapy (dCellVax). 

Regen BioPharma is also modulating vital molecular processes in cancer stem cells by way of its patented molecular targeting approaches (BORIS). In addition, it is repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients (HemaXellerate). 

Regen BioPharma is centering on small molecules to activate and inhibit its main target of interest, NR2F6. The Company is continuing to develop the NR2F6 program in-house before entering into any potential partnerships. It has granted CheckPoint Immunology an exclusive international license to develop and commercialize Regen's NR2F6 technology for human therapeutic use. The objective of the license grant is the separation of Regen BioPharma’s small molecule technology from its other Intellectual Property (IP) to facilitate any future transactions involving small molecule therapies focused on the NR2F6 checkpoint.

Regen BioPharma previously reported that its researchers identified a series of small molecule drugs, which inhibit NR2F6 as well as activate human immune cells ex-vivo. Evidence provided by studies suggest that NR2F6 represses the body's immune response against tumors. Therefore, inhibiting NR2F6 may lead to enhanced immune response against cancerous tumor cells.

Harry Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen BioPharma, said, "Based on the known activities of NR2F6, we expect that inhibiting its activity will lead to increased T cell activation. We found that several of our NR2F6 antagonists can activate human immune cells, such as T cells, leading to increased IL-17a production in a concentration-dependent manner."

Recently, Regen BioPharma reported that its researchers determined that its lead NR2F6 small molecule agonist, RG-NAH005, is now ready for testing in animal models of inflammatory bowel disease (IBD). Regen will pursue this testing as a joint venture (JV) with Zander Therapeutics, Inc. Zander Therapeutics has been granted an exclusive license by Regen to develop and commercialize the Company's NR2F6 IP for veterinary applications.

Regen BioPharma, Inc. (RGBP), closed Friday's trading session at $0.001, up 25.00%, on 3,780,135 volume with 14 trades. The average volume for the last 3 months is 15,048,946 and the stock's 52-week low/high is $0.0005/$0.025.

chart

True Nature Holding, Inc.  (TNTY)

Real Pennies, MarketWatch, InvestorsHub, Marketwired, Stockhouse, and OTC Markets reported  on True Nature Holding, Inc. (TNTY), and  today we are reporting on  the Company,  here at the QualityStocks Daily Newsletter. 

True Nature Holding, Inc.’s business plan considers a roll-up of businesses in the compounding pharmacy industry. The plan contemplates  manifold  acquisitions of businesses that  have conventionally operated locally, but that have specialty formulations  that  may have a larger market.  The Company is  targeting the acquisition of pharmacies that serve the human, and in some  cases, pet markets. True Nature Holding  has its corporate office in Atlanta, Georgia.

True Nature Holding’s focus is on the consolidation of the compound pharmacy industry.  Its plan is to acquire a series of businesses that specialize in compounding pharmacy activities,  primarily direct to consumers, and to doctors and veterinary professionals.  Pharmaceutical compounding is performed  in compounding pharmacies. It is the creation of a specific pharmaceutical product to fit the exclusive need of a patient.  

The Company  has acquired 100 percent of the membership interests of Newco4pharmacy, LLC. Newco4pharmacy is a development stage business targeted  at establishing a network of compounding pharmacies. 

True Nature  is creating a  blend  of human  and veterinary  businesses,  and  a balance of cash oriented operations, and more  usual  insurance based operations.  The Company expects to create three operating subsidiaries to hold its planned acquisitions, while maintaining its present holding company structure for the publicly held entity.  The expectation is that  all the new subsidiaries will be wholly-owned, single member LLC's, controlled and managed by the public company. 

True Nature Holding’s  intention is to  establish  a joint venture (JV) for-profit subsidiary; True Nature Community Health, Inc.  This will be owned by the public company, and  a newly formed not-for-profit entity; The True Nature Community Health Foundation. It is launching this new initiative targeted  at supporting the need for lower cost pharmaceuticals within the medically underserved small town and rural marketplaces.

True Nature Holding is in the process of acquiring  the  newly formed subsidiary; True Nature Community Health, Inc. (Community Health Subsidiary). It will have an 80 percent  ownership in the Community Health Subsidiary. The remaining 20 percent  ownership will be held by not-for-profit organizations.

Recently, True Nature Holding released an update to its shareholders on its strategy. This includes potential acquisitions, financing prospects, and its position concerning plans to participate in the Cryptocurrency and Blockchain space.

Regarding acquisitions, Dr. Jordan Balencic, Chairman, and interim Chief Executive Officer, said, "First, in alignment with our current business model, we have three near-term acquisition prospects at this time. The smallest is an asset acquisition involving the operating assets of a compounding pharmacy operation near West Palm Beach, Florida… Secondly, we have had some discussions with a group of investors who hold interests in a set of clinics, diagnostic facilities, and pharmacies, generally in Florida, mostly in the Dade and Broward county markets.”

Dr. Balencic continued, "We have continued conversations with other pharmacy operators with whom we have had long-term relationships, and subject to terms and financing, could move on those in early 2018 as well as the others previously mentioned."

True Nature Holding, Inc. (TNTY), closed Friday's trading session at $0.0395, up 100.2027%, on 1,175,136 volume with 126 trades. The average volume for the last 3 months is 319,434 and the stock's 52-week low/high is $0.019729999/$0.219899997.

chart

Validian Corp. (VLDI)

Value Penny Stocks, Epic Stock Picks, Hot Stock Profits, StockMarketIntel, TopPennyStockMovers, Profit Sensation, Stock News Now, Damn Good Penny Picks, Penny Picks, PREPUMP STOCKS, Penny Stock Newsletter, Pumps and Dumps, PennyStocks24, and OTC Stock Review reported previously on Validian Corp. (VLDI), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Validian Corp. provides software products for public and private enterprises. In essence, the Company is a top innovator in cyber-security technology. Validian develops and markets solutions to protect against the threats of today's digital world. Validian is first-to-market to provide secure storage, access, and transfer of digital information on wired, wireless, or mobile networks over the Internet. Listed on the OTC Markets Group’s OTCQB, Validian is headquartered in Ottawa, Ontario.

The Company’s technology enables the next generation of secure Cloud Computing, Cloud Storage, Distributed Computing and Web Application and WebPortal Access and Usage for desktop and laptop computers, servers, tablets, and Smartphones. Validian’s products include Validian Protect, which embeds its technology into any application.

Validian provides solutions that can undergo customization to the client's business process to ensure end-to-end authenticity, integrity, and custody of high value digital assets. Validian’s corporate mission is to deliver innovative information protection solutions that help government agencies, enterprises, and individuals in lessening the impact of theft, disclosure, non-compliance, or malicious tampering with digital assets.

The Company has extended its core technology, ValidianProtect. It is now the first cyber security technology to cover and seamlessly protect the Complete Life Cycle of Data with secure access, retrieval, transfer, receipt, storage, and usage of digital information on all devices, operating systems, and technology platforms.

Validian redesigned its ValidianProtect technology to include a group of downloadable, re-usable, feature modules. These make it possible for a programmer to quickly and easily add any combination of a substantial number of pre-built, commonly used functions and first-to-market differentiating features to or from any application, thus saving them numerous man-years of previously extra development time.

In August 2017, Validian announced that it recently completed version 3.3 of its inventive cybersecurity technology. This technology seamlessly protects the Complete Life Cycle of Data on all major technology platforms, operating systems, and devices. This completion consisted of minor modifications in addition to the migration and upgrades already completed to Microsoft Windows 10 and the Azure Cloud platform, as well as to recent versions of Google Android, Apple OS and iOS, and to Red Hat Linux.

Recently, Validian confirmed that some of the large corporations now in talks with Validian concerning strategic partnership agreements are interested in utilizing the Company’s technology to secure and enhance automotive connectivity and communications. This includes vehicle to vehicle communications.

Validian Corp. (VLDI), closed Friday's trading session at $0.025, up 19.0476%, on 1,496,942 volume with 47 trades. The average volume for the last 3 months is 434,663 and the stock's 52-week low/high is $0.00575/$0.100000001.

chart

MamaMancini's Holdings, Inc. (MMMB)

TheMicrocapNews, TaglichBrothers, Stock News Now, SmallCapVoice, Marketbeat.com, and OTC Markets Group reported earlier on MamaMancini's Holdings, Inc. (MMMB), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

MamaMancini's Holdings, Inc. is a marketer of specialty pre-prepared, frozen, and refrigerated all natural food products (as defined by the United States Department of Agriculture - USDA). The Company is a marketer and distributor of a line of beef meatballs and turkey meatballs all with sauce, five cheese stuffed beef and turkey meatballs all with sauce, original beef and turkey meatloaves, chicken parmesan, stuffed peppers, and other like Italian cuisine products. MamaMancini’s Holdings is headquartered in East Rutherford, New Jersey.

MamaMancini's distribution channel includes major retailers and distributors, including Costco, Publix, Shop Rite, Jewel, Save Mart, Lucky's, Lunds and Byerlys, SuperValu, Safeway, Albertsons, SpartanNash, Bashas, Whole Foods Market, Hy-Vee, Sam's Club, and Shaw's. Major retailers and distributors also include Kings, Roche Bros., Key Foods, Stop & Shop, Giant, Giant Eagle, Foodtown, Kroger, Shoppers, King Kullen, Lowes, Central Market, Weis Markets, Ingles, Food City, The Fresh Market, Sysco, Burris Foods, C&S, and Driscoll Foods.

In addition, the Company sells an assortment of its products on air and online on QVC, which is the world's largest direct to consumer marketer.

MamaMancini's offers Slow Cooked Italian Sauce and Meatballs, Stuffed Meatballs, Slow Cooked Sauces, Slow Cooked "Italian Style Sauce" and Meatballs - Gluten Free, Slow Cooked Italian Sauce and Meatballs made without Antibiotics, bacon gorgonzola beef meatloaf, and its Italian Style Meatloaf. It also has Food Service offerings and offers Bulk Deli Orders.

In August, MamaMancini's Holdings announced that it signed a Letter of Intent (LOI) to acquire Joseph Epstein Food Enterprises, Inc. (JEFE), a manufacturer of food products, which has been the sole manufacturer of MamaMancini’s products since inception. Under the agreed terms, no cash would be exchanged between the parties. JEFE is currently owned by the Chief Executive Officer and President of MamaMancini's Holdings, who in total owns roughly 44 percent of the Company's common stock.

MamaMancini's Holdings financial results for Q2 of fiscal year 2018, ended July 30, 2017. Q2 of fiscal year 2018 Revenue increased 69 percent to $7.0 million versus $4.1 million in the previous year period. Net Income for the second quarter was $24,000 in comparison to a Net Loss of $(277,000) in the previous year period. This represents a $301,000 improvement.

Net Loss available to common stockholders was $(5,000), or $0.00 per diluted share, during Q2 of fiscal 2018, versus a Net Loss of $(324,000), or $(0.01) per diluted share in the same quarter the year prior.

Recently, MamaMancini's Holdings announced that its Beef and Turkey Stuffed Meatballs were voted by the QVC Shopping Network audience as the #1 product in the 'Quick and Easy Meals' category during QVC's 2017 Audience Choice Awards Program, yesterday September 13, 2017.

MamaMancini's Holdings, Inc. (MMMB), closed Friday's trading session at $0.60, up 25.00%, on 161,438 volume with 68 trades. The average volume for the last 3 months is 16,887 and the stock's 52-week low/high is $0.330000013/$1.00.

chart

The QualityStocks Company Corner

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) (GGB or the Company) announced that, effective today, Gary Galitsky has resigned from the Board of Directors in order to focus on other business endeavors.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Friday's trading session at $1.3519, up 5.4524%, on 251,591 volume with 266 trades. The average volume for the last 3 months is 403,129 and the stock's 52-week low/high is $1.12569999/$5.20499992.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings (CSE: TCAN) (FRA: TH8) on Thursday announced that it has signed a binding agreement to acquire all the outstanding shares of Lyfted Farms Inc. for a purchase price of $6,300,000. The purchase price will be comprised of $5,550,000 in cash and the issuance of 1,000,000 TransCanna common shares. To view the full press release, visit: http://nnw.fm/UcL5c.

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) brings together a rapidly growing portfolio of cannabis and hemp-related brands and services, with a closed-loop ecosystem approach rooted squarely in the company’s ownership of a 196,000-square-foot, vertically integrated facility in California. The company has developed a two-year, four-phase plan aimed at developing proprietary brands and creating a self-contained ecosystem that ensures reliability, consistency, quality and scale.

Ecosystem

TransCanna’s cannabis facility in Modesto, California, is strategically located less than a three-hour drive from the majority of all major cities in the state. The tri-level building provides internal control of everything needed for the seed-to-sale cycle, from growing and manufacturing to extraction, bottling, transportation and distribution. The facility, which recently went through an US$8 million renovation, is upgraded with a premium quality HVAC system and highly insulated roof to help reduce power costs, which already are some of the lowest in California.

The company has set 2020 goal for implementation of its full-service software platform, 420 Global, which will interact with every aspect of production flow, business development and the sales process.

Growing Portfolio

Acquisitions slated to be completed in June include Goodfellas Group LLC, a full-service advertising and marketing agency for the U.S. cannabis and hemp industries. Under the deal, TransCanna will also be acquiring Daily Cannabis Goods, a pre-rolled brand with nominal start-up costs and superior SKU velocity with cannabis products available at more than 30 dispensaries throughout California.

On Deck

The company has moved to acquire organic hemp-infused CBD coconut oil Biovelle (www.Biovelle.com). Biovelle is non-GMO, vegan and gluten free, with coconut sourced from plantations in the Philippines and American grown hemp from farms in Colorado.

TransCanna has also moved to further secure a growing foothold in cannabis edibles via a non-binding letter of intent with Persuasion Brewing Co., located near the company’s flagship facility in Modesto. The goal is to establish a Persuasion Brewing division at the main facility, which will produce a variety of different CBD infusion non-alcoholic beers.

Similarly, the company has recently executed a non-binding LOI with SolDaze (Tres Ojos Naturals, LLC) to gobble up the branding asset package of this California manufacturer of cannabis-infused fruit snacks (www.soldazesnacks.com).

Management

TransCanna’s management team consists of seasoned agriculture and consumer goods-oriented veterans.

Director, CEO and Chairman James Pakulis has 30 years of experience working with public and private entrepreneurial companies in a variety of emerging sectors. He has been on the front lines of the California cannabis industry for nearly a decade. He was CEO and chairman in 2010 of General Cannabis, Inc., which wholly owned the popular Weedmaps brand. Pakulis oversaw the growth of General Cannabis from pre-embryonic stages to over $16 million in revenue in less than two years, reaching a market cap of approximately $480 million.

Director and President Arni Johannson brings over 30 years of investing experience in the Canadian capital markets. He has built and or funded over 50 startups from around the world. He is president of Canadian Nexus Ventures and has been instrumental in providing guidance to pre- and post IPO companies, as well as guidance and oversight for corporate governance.

Stephen Giblin, board director, is an accomplished leader in the global hospitality, technology and real estate industries with a demonstrated track record of value creation. Juan Pablo Flores, independent director, is an attorney with more than 25 years of legal experience with a strong background in municipal, government, real estate, corporate and general civil law litigation.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

TransCanna Holdings Inc. (CSE: TCAN), closed Friday's trading session at $1.3519, up 5.45%, on 251,591 volume with 94 trades. The average volume for the last 3 months is 403,129 and the stock's 52-week low/high is $0.629999995/$7.78999996.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Cannabis-based wellness company Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) continues scaling up its brand visibility following the opening of two new premier cannabis locations in British Columbia under its subsidiary, City Cannabis Corp. Also today, NetworkNewsWire released a report highlighting the company which examines how WLDFF recently finalized its acquisition of City Cannabis Corp. in a deal that includes four operating retail cannabis stores and renovations to other locations. To view the full article, visit: http://nnw.fm/38ZfZ.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed Friday's trading session at $0.35021, up 0.75666%, on 2,833 volume with 2 trades. The average volume for the last 3 months is 14,103 and the stock's 52-week low/high is $0.250999987/$1.12999999.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

The evolution of digital cellular networks to a higher-speed 5G capacity is driving new revenue for Spectrum Global Solutions Inc. (OTCQB: SGSI), an end-to-end U.S. network service provider that’s ideally positioned to serve businesses setting up infrastructure for participation in the new 5G wave of technology.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed Friday's trading session at $0.03, up 7.1429%, on 82,650 volume with 9 trades. The average volume for the last 3 months is 215,549 and the stock's 52-week low/high is $0.014999999/$1.49.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade Inc. (OTC:SGMD) announces the availability of an audio press release broadcast titled, “Hemp Set to Overtake Tobacco in Kentucky Amid Boom for Growers, Suppliers,” and produced by NetworkNewsWire (“NNW”). To hear the CannabisNewsAudio version, visit: http://cnw.fm/FPq1f. To read the full editorial, visit: http://cnw.fm/r34IT.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed Friday's trading session at $0.0164, up 0.613497%, on 5,739,792 volume with 145 trades. The average volume for the last 3 months is 4,353,760 and the stock's 52-week low/high is $0.00975/$0.164000004.

Recent News

chart

Quest Patent Research Corp. (OTCQB: QPRC)

The QualityStocks Daily Newsletter would like to spotlight Quest Patent Research Corp. (OTCQB: QPRC).

New York City-based Quest Patent Research (OTCQB: QPRC) is an intellectual property (“IP”) asset-management firm that operates through majority-owned and controlled subsidiaries and helps asset owners fully realize the potential of their intellectual properties. To view the full article, visit: http://nnw.fm/6tQSo.

Quest Patent Research Corp. (OTCQB: QPRC) is a New York City-based intellectual property (IP) asset management firm operating through majority-owned and controlled operating subsidiaries to deliver financial, strategic and legal resources for IP monetization. Quest currently owns, controls or manages over 115 patents across 11 intellectual property portfolios (https://www.qprc.com/portfolio). The company generates revenues from patent licensing fees of its IP property portfolios and from licensed packaging sales.

Quest creates shareholder value through investment and management interests in intellectual property assets, such as patents, trademarks, copyrights, novel inventions and trade secrets. Through its business, shareholders have the opportunity to participate across a broad portfolio of dynamic assets in the burgeoning intellectual property space.

Objectives

Invention, protection and commercialization of IP require a deep understanding of dynamic technologies, market fundamentals, competitive landscapes and engagement strategies. Often, IP asset owners/stakeholders lack the requisite resources, experience and/or capacity to access the latent value of their IP assets and opportunities. Quest seeks to bridge this gap, partnering with asset owners – such as inventors, businesses, corporations and law firms – to help them fully realize the value of IP assets through:

  • IP Valuation
  • Structured Licensing Programs
  • Patent Prosecution
  • Partial or Full Liquidity
  • Portfolio Evaluation
  • Portfolio Maintenance
  • Legal Advisory
  • Attorney/Investor Referral
  • Patent Acquisition/Liquidation

At Quest, each partnership is treated as its own entity, with its own focused management comprised of Quest employees and seasoned industry associates. Many of technologies are placed in a wholly owned subsidiary of Quest, benefitting from the broader expertise of the company’s leadership.

Management

Quest’s management team delivers a wealth of experience in strategic business management, intellectual property, finance and marketing. The company’s internal resources, in tandem with its external network of financial, legal and managerial professionals, can develop creative solutions to the myriad of challenges involved in monetizing IP. Quest’s structured diligence and deployment procedures mitigate risks, maximize returns and deliver value to IP owners and shareholders alike.

Quest CEO and President Jon Scahill was the founder and managing director of the Urban-Rigney Group, LLC, a private consultancy specializing in new business/new venture development, operations optimization, and strategic analysis. Prior to launching his consultancy business, Mr. Scahill held numerous positions in sales and marketing, technical management, and product development in the consumer products/flexible packaging arena. Mr. Scahill holds a B.S. in chemical engineering from the University of Rochester, an MBA from Rochester’s Simon Graduate School of Business, and a JD from Pace University Law School. He is a registered patent attorney admitted to practice in New York, Florida, the District of Columbia and before the United States Patent and Trademark Office.

Quest Chief Technology Officer Timothy Scahill recently completed a merger and buyout of Managed Services Team LLC, an IT Managed Services provider. Prior to Managed Services Team, he was president of Layer 8 Group Inc., which merged with Structured Technologies Inc. to form Managed Services Team LLC. In his roles he was responsible for business strategy, acquisition, execution, as well as financial management. Mr. Scahill’s entrepreneurial acumen and proven record of successful management with sole discretionary responsibility, demonstrate the scope of his capability and his value to delivering results. He successfully completed his term on the boards of the Upstate New York Technology Council and Pariemus Rochester. Mr. Scahill completed a six-year term as secretary, executive council and a seat on the board of directors for Habitat for Humanity. He has served as president of the Western New York chapter of The Entrepreneurs Organization and continues to serve on the board as accelerator chair. Mr. Scahill is currently performing Cyber Intelligence, Security and Information Assurance work for an undisclosed organization.

Peter LaFauci is president of CFO Solutions, a Rochester, NY-based consulting firm offering knowledge-based financial and accounting solutions for emerging to medium-size companies. Mr. LaFauci is a seasoned executive with over 25 years of proven success in developing, leading and executing strategy in both publicly and privately held companies within the advertising, software development, internet, manufacturing and emerging technologies sectors. Peter possesses strong research and analytical skills as well as interpreting, summarizing and communicating financial and business information to others. Mr. LaFauci is a graduate of Saint Bonaventure University.

Quest Patent Research Corp. (OTCQB: QPRC), closed Friday's trading session at $0.014, up 1.5597%, on 164,804 volume with 7 trades. The average volume for the last 3 months is 257,168 and the stock's 52-week low/high is $0.0013/$0.039999999.

Recent News

chart

CloudCommerce (OTCQB: CLWD)

The QualityStocks Daily Newsletter would like to spotlight CloudCommerce (OTCQB: CLWD).

CloudCommerce Inc. (CLWD) was featured today in a report by NetworkNewsWire on data-driven marketing. Data is becoming the one thing that’s bound to give companies a significant competitive advantage, as a Mind the Data Gap report suggests (http://nnw.fm/M3aYs). Its power, however, is still largely untapped due to the fact that companies often struggle with inaccessible customer data or a lack of effective analytical solutions. Also today, NetworkNewsWire released a report on the company detailing how CloudCommerce Inc. (CLWD) Is ‘One to Watch.’ To view the full article, visit: http://nnw.fm/RvW2o.

CloudCommerce (OTCQB: CLWD) is a leading provider of audience-driven business intelligence and marketing solutions. Together with its wholly owned subsidiaries, CloudCommerce delivers invaluable end-to-end business intelligence and marketing solutions through a range of services and capabilities.

Flagship Solution

SWARM is an end-to-end solution that applies advanced data science, behavioral science, artificial intelligence and market research techniques to deliver powerful audience-driven business intelligence that converts opportunities into business success.

Through marketing, brand perception, customer-relationship management, human-resources management and operational logistics applications, CloudCommerce’s SWARM solution helps businesses determine who to talk to, what to say and how to motivate targeted audiences to take meaningful action.

The Market

Marketers have largely taken a blanket approach to communication. The same messages are often sent across an entire customer audience with little regard for how different groups of people communicate, build communities and develop their purchasing habits. When marketers do segment audiences, they use objective selection criteria such as income, geography, education or purchase history to deduce attitudes or intentions.

However, research shows that motivations and feelings are much more accurate at predicting behavior. The challenge for businesses is that these factors are also the hardest to gather from audience data. CloudCommerce provides that audience-intelligent data through SWARM, its proprietary behavioral-science approach to audience creation and communication. Through SWARM, CloudCommerce helps marketers identify consumer motivations and triggers in order to effectively predict and influence actions. When companies influence action, they can change opinions, gather support, motivate purchases and inspire change.

In a fast-developing global business intelligence market estimated to grow from $16.3 billion in 2016 to $34.3 billion by 2022, CloudCommerce stands apart as an innovator and true partner, able to deliver data-driven intelligence and solutions that enable its customers to strengthen their brands, deliver their messages and reach their goals.

SWARM Products

THE SWARM—Intelligent Audience Building
The core of the CloudCommerce solution – and what separates CloudCommerce from other audience data companies – is the company’s unique approach to audience building. The concept of “personas” has been around for decades, but CloudCommerce takes that concept to the next level. The SWARM was developed to identify not only who to talk to but also what to say in order to motivate target audiences to take meaningful action. Using CloudCommerce’s proprietary clustering and behavioral analysis techniques, businesses can identify target audiences and deliver messages that are more focused and efficient. CloudCommerce not only helps its client partners find the right people to talk to but also identifies the most powerful message to send.

BUZZ—Behavior-Based Market Research
Market research is evolving. Research techniques developed and used today are more sophisticated and backed by strong data science. Despite these changes, many traditional research firms have failed to innovate: small sample sizes, survey design bias, improper weighting and gut-intuition sampling are just some of the issues that plague the market-research industry. Through BUZZ, CloudCommerce has automated the market research process to provide a level of statistical depth beyond what traditional firms can offer. BUZZ offers businesses the ability to put their finger on the pulse of the marketplace in the moment. Using a wide range of internal and external data sources such as customer data, social media activity, and micro and macro trends, BUZZ deduces attitudes, emotions and opinions.

HIVE—Redefined Geographic Targeting
Conventional geographic audience targeting is outdated. Arbitrary units of location such as counties, cities, DMAs and regions were created centuries ago based on land-rights ownership. Their use in understanding people’s behavior, purchase habits and underlying values is minimal. CloudCommerce has found a much more powerful, efficient and effective way of targeting by clustering people into granular geographic tribes called HIVES. HIVES are defined by attributes such as common language (e.g., colloquialisms), shared experience and narratives (e.g., climate, history), and concentrated demography and biology (e.g., ethnicity, age). Based on the needs of its clients, CloudCommerce can completely redraw the geographic lines based on various Hive selection criteria. Using this exclusive HIVE approach, CloudCommerce clients experience more efficient and effective marketing, make more intelligent business decisions and enjoy more growth.

HONEY—Advanced Reporting and Visualization
Advanced-audience, data-analysis technologies are useless if they don’t produce simple, powerful and actionable business intelligence. HONEY comes with user-friendly reporting and visualization tools to organize and explain all of the advance-data science into a simple-to-understand format for decision makers. HONEY combines the intelligence of client CRM data with third-party consumer data and targeted market research to create a powerful foundation for any audience-intelligence solution.

Subsidiaries

Data Propria
Data Propria delivers the highest Return on Investment (“ROI”) for their customers’ digital marketing campaigns, by utilizing sophisticated data science to identify the correct universes to target relevant audiences. Their ability to understand and translate data drives every decision they make. By listening to and analyzing their customers’ data they are able to make informed decisions that positively impact their customers’ business. Data Propria leverages industry-best tools to aggregate and visualize data across multiple sources, and then their data and behavioral scientists segment and model that data to be deployed in targeted marketing campaigns. They have data analytics expertise in retail, wholesale, distribution, logistics, manufacturing, political, and several other industries.

Parscale Digital
Parscale Digital helps their customers get their message out, educate their market and tell their story. They do so creatively and effectively by deploying powerful call-to-action digital campaigns with national reach and boosting exposure and validation with coordinated advertising in print media. Parscale Digital’s fully-developed marketing plans are founded on sound research methodologies, brand audits and exploration of the competitive landscape. Whether their customer is a challenger brand, a political candidate, or a well-known household name, Parscale Digital’s strategists are skilled at leveraging data and creating campaigns that move people to make decisions.

Giles Design Bureau
Giles Design Bureau approaches branding from a “big picture” perspective, establishing a strong identity and then building on that to develop a comprehensive branding program that tells the customer’s story, and articulates what sets the customer apart from their competitors and establishes the customer in their market.

WebTegrity
WebTegrity develops commerce-focused, user-friendly digital websites and apps that elevate their customer’s marketing position and draw consumers to their products and services. Their platform-agnostic approach allows WebTegrity to architect and build solutions that are the best fit for each customer. Once the digital properties are built, their experts will help manage and protect the website or app and provide the expertise needed to scale the infrastructure needed as the customer’s business grows.

Leadership

Andrew Van Noy, CEO & Chairman of CloudCommerce Board of Directors
Andrew Van Noy has been a director of CloudCommerce since November 2012, president of the company since April 2012, and the CEO of the company since August 2012. He also served as executive vice president of CloudCommerce from November 2011 to April 2012 and vice president of Sales and Marketing of the company from May 2011 to November 2011. From January 2009 to April 2011, Van Noy served as the vice president of Sales and Marketing for PageTransformer, which provided web and software development for iPad, iPhone and Android devices. Van Noy came to CloudCommerce with experience in digital marketing, private equity and investment banking. During his years at the company, Van Noy led the efforts to rebrand and restructure the business and presided over the acquisition of a number of companies. Van Noy graduated from BYU with a Bachelor of Science degree.

Gregory Boden, CFO and Board of Directors
Gregory Boden became a director at CloudCommerce in November 2011 and in February 2013 was named corporate secretary. In April 2012, Boden was also appointed CFO. In addition, Boden is the managing partner of a private equity company. Prior to joining the CloudCommerce team, Boden managed the franchise accounting and cash application departments of Select Staffing, a nationwide staffing company and was an accountant at KPMG LLP. Boden earned his master of accountancy degree from the University of Denver.

Brad Parscale, Board of Directors
Brad Parscale creates web-marketing strategies and oversees all technical and functional aspects of these strategies. Originally from Kansas, Parscale spent five years in California before moving to San Antonio in 2004 to establish Parscale Media, a successful web-marketing firm. His 2011 partnership with Jill Giles formed Giles-Parscale Inc. In 2016, Parscale was named digital director for the Donald J. Trump presidential campaign.

Zachary Bartlett, VP of Corporate Development and Board of Directors
Zachary Bartlett has been a director of the company since July 2012 and was appointed vice president of Corporate Development in January 2018. Bartlett has also served as vice president of Communications and an independent contractor assisting with project management matters. Prior to joining CloudCommerce, Bartlett was the creative director at Crowbar Studios Inc., a graphic design and web development firm he founded in 2008. From 2004 to 2008, he held the position of art and brand consultant at Demon International, a snowboard accessories company. Bartlett earned his bachelor of fine arts degree in graphic design from Brigham Young University.

CloudCommerce (OTCQB: CLWD), closed Friday's trading session at $0.0049, up 22.50%, on 5,087,918 volume with 39 trades. The average volume for the last 3 months is 577,277 and the stock's 52-week low/high is $0.003299999/$0.0228.

Recent News

chart

Neutra Corp. (OTCQB: NTRR)

The QualityStocks Daily Newsletter would like to spotlight Neutra Corp. (NTRR).

Early-stage research and development company Neutra (OTCQB: NTRR) is continuing its efforts to develop its portfolio. The company recently entered two LOIs for emergent-hemp retail brand Vivis and hemp-cultivator J3 Holdings. To view the full article, visit: http://nnw.fm/GO7ak. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. An audit done by a marijuana business association has revealed that the number of black market cannabis industry players is thrice the number of the licensed marijuana businesses in the state.

Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.

Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.

Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.

Acquisitions

  • Vivis – Neutra is expanding its market presence in the rapidly growing hemp-derived CBD market with a letter of intent to acquire Vivis, an emerging retail brand of hemp-based health and nutritional products. Vivis’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With Vivis as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
  • J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.

Partners

  • Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
  • ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.

Leadership

Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.

Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.

Neutra Corp. (OTCQB: NTRR), closed Friday's trading session at $0.002, up 2.5641%, on 16,300,777 volume with 81 trades. The average volume for the last 3 months is 23,016,106 and the stock's 52-week low/high is $0.0012/$0.097350001.

Recent News

chart

Trxade Group Inc. (TRXD)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (TRXD).

Trxade Group Inc. (TRXD) was featured today in a publication from NetworkNewsWire. Competition continues to be a major challenge for small and independent pharmacies to overcome. As mass merchants try to consolidate with smaller industry representatives in an attempt to dominate the market, many of the independent pharmacies could perish, as a pharmacy outlook report suggests (http://nnw.fm/Sy2IS). Also today, NetworkNewsWire released an additional report on the company detailing how integrated pharmaceutical services company Trxade Group (OTCQB: TRXD) reported record revenues and other improvements to its top and bottom lines in a recent news release announcing the company’s second-quarter financial results. To view the full article, visit: http://nnw.fm/Z2CvQ.

Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE's programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.

Management Team

Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary

Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer

Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (TRXD), closed Friday's trading session at $1.20, even for the day, on 500 volume. The average volume for the last 3 months is 3,595 and the stock's 52-week low/high is $0.230000004/$1.29999995.

Recent News

chart

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was featured today in the 420 with CNW by CannabisNewsWire. An audit done by a marijuana business association has revealed that the number of black market cannabis industry players is thrice the number of the licensed marijuana businesses in the state. The audit, whose findings were made public on Wednesday, indicates that there are 2,835 illegal marijuana businesses operating within California while the statistics from the Bureau of Cannabis Control show that only 873 companies are licensed to conduct marijuana-related business activities within the state.

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Friday's trading session at $4.50, off by 0.881057%, on 726,187 volume with 2,654 trades. The average volume for the last 3 months is 1,031,209 and the stock's 52-week low/high is $2.97000002/$8.43999958.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Automotive technology innovator Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX) this morning announced its entry into a strategic cooperation agreement with Wuhan Guide Infrared Co. Ltd. (002414.SZ), a $2.7 billion Chinese corporation traded on the Shenzhen Stock Exchange. To view the full press release, visit: http://nnw.fm/BWh6Z.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed Friday's trading session at $1.49, off by 0.666667%, on 825,397 volume with 2,420 trades. The average volume for the last 3 months is 520,357 and the stock's 52-week low/high is $0.697000026/$3.16000008.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) announces the availability of an audio broadcast titled, “Technological Innovation Pushes Bounds of Edible Cannabis Market.” To hear the CannabisNewsAudio version, visit: http://cnw.fm/TDyO4. To read the full editorial, visit: http://cnw.fm/D7Cta.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed Friday's trading session at $0.2955, off by 2.385%, on 255,744 volume with 86 trades. The average volume for the last 3 months is 229,866 and the stock's 52-week low/high is $0.189099997/$0.850000023.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (OTCQB: SHRG), a diversified holdings company, is revolutionizing the direct-selling industry by providing the tools needed for its independent distributors, or Elepreneurs, to be successful. To view the full article, visit: http://nnw.fm/mGPq9.

Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services Global Corporation (SHRG), closed Friday's trading session at $0.21, off by 8.6957%, on 34,800 volume with 8 trades. The average volume for the last 3 months is 28,426 and the stock's 52-week low/high is $0.090000003/$0.3944.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

VPR Brands (OTCQB: VPRB), a market leader and pioneer in electronic cigarettes and vaporizers for nicotine, cannabis and cannabidiol (“CBD”), today announced its intent to fully comply with any FDA guidelines regarding flavors for electronic cigarettes. To view the full press release, visit: http://nnw.fm/3bYCM.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit www.goldlinehemp.com for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed Friday's trading session at $0.05794, off by 3.4333%, on 145,600 volume with 10 trades. The average volume for the last 3 months is 126,195 and the stock's 52-week low/high is $0.033799998/$0.119999997.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.